Stay updated on Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page footer removes the HHS Vulnerability Disclosure link and adds a new revision note, Revision: v3.3.3 (replacing the previous v3.3.2).
    Difference
    0.1%
    Check dated 2025-12-23T09:17:21.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:03:14.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Removed 'Tainan City, Taiwan' from the locations and added 'Tainan, Taiwan'.
    Difference
    0.4%
    Check dated 2025-11-17T15:00:30.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The updates are minor visual and layout adjustments to the study page with no substantive changes to core information such as eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:30:55.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-05T10:11:43.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.